Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q1

8129.TEDINET S100OXRX
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥323.4bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥1.27T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥308.8bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥635m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥3.1bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥18.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥3.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥2.4bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.7bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥1.7bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥710.1bnat 2022-06-30Cons.Assets
Total assets¥702.4bnat 2022-03-31Cons.Assets
Total assets¥697.5bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥466.3bnat 2022-06-30Cons.Liabilities
Total liabilities¥461.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥243.7bnat 2022-06-30Cons.Net assets
Net assets / equity¥241.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥237.4bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥94.4bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥94.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥29.222022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥189.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥24.552021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥26.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥174.482021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥22.552021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio34.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.0%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥401m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥133m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-06-30¥612m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-06-30¥288m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-06-30¥311.8bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-06-30¥299.4bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥356m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥94m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥338.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥323.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥14.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥14.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥14.5bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥466m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2021-04-01 → 2021-06-30¥22.5bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2021-04-01 → 2021-06-30¥22.5bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2021-04-01 → 2021-06-30¥350m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2021-04-01 → 2021-06-30¥403m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2021-04-01 → 2021-06-30¥195m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2021-04-01 → 2021-06-30¥297.6bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2021-04-01 → 2021-06-30¥284.9bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2021-04-01 → 2021-06-30¥554m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥1.3bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥966m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥305m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥0
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥323.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥308.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥14.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 420
ItemContextValueUnit
Non controlling interestsPrior1YearInstant199000000JPY
Non controlling interestsCurrentQuarterInstant207000000JPY
Net assetsPrior1YearInstant241281000000JPY
Net assetsCurrentQuarterInstant243743000000JPY
Liabilities and net assetsPrior1YearInstant702376000000JPY
Liabilities and net assetsCurrentQuarterInstant710058000000JPY
Net salesPrior1YTDDuration308828000000JPY
Net salesCurrentYTDDuration323397000000JPY
Cost of salesPrior1YTDDuration284059000000JPY
Cost of salesCurrentYTDDuration297884000000JPY
Gross profitPrior1YTDDuration24769000000JPY
Gross profitCurrentYTDDuration25513000000JPY
Directors compensations salaries and allowances sgaPrior1YTDDuration10074000000JPY
Directors compensations salaries and allowances sgaCurrentYTDDuration10004000000JPY
Provision for bonuses sgaPrior1YTDDuration1645000000JPY
Provision for bonuses sgaCurrentYTDDuration1712000000JPY
Provision for directors bonuses sgaPrior1YTDDuration13000000JPY
Provision for directors bonuses sgaCurrentYTDDuration10000000JPY
Retirement benefit expenses sgaPrior1YTDDuration61000000JPY
Retirement benefit expenses sgaCurrentYTDDuration69000000JPY
Welfare expenses sgaPrior1YTDDuration1934000000JPY
Welfare expenses sgaCurrentYTDDuration1929000000JPY
Vehicle expenses sgaPrior1YTDDuration244000000JPY
Vehicle expenses sgaCurrentYTDDuration266000000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration-19000000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration-86000000JPY
Depreciation sgaPrior1YTDDuration1503000000JPY
Depreciation sgaCurrentYTDDuration1360000000JPY
Amortization of goodwill sgaPrior1YTDDuration82000000JPY
Amortization of goodwill sgaCurrentYTDDuration75000000JPY
Rent expenses sgaPrior1YTDDuration2013000000JPY
Rent expenses sgaCurrentYTDDuration1997000000JPY
Taxes and dues sgaPrior1YTDDuration581000000JPY
Taxes and dues sgaCurrentYTDDuration532000000JPY
Exepences before deduction of temporary consumption tax payment sgaPrior1YTDDuration1617000000JPY
Exepences before deduction of temporary consumption tax payment sgaCurrentYTDDuration1619000000JPY
Other sgaPrior1YTDDuration4382000000JPY
Other sgaCurrentYTDDuration4623000000JPY
Selling general and administrative expensesPrior1YTDDuration24134000000JPY
Selling general and administrative expensesCurrentYTDDuration24116000000JPY
Operating incomePrior1YTDDuration635000000JPY
Operating incomeCurrentYTDDuration1397000000JPY
Interest income noiPrior1YTDDuration14000000JPY
Interest income noiCurrentYTDDuration13000000JPY
Dividends income noiPrior1YTDDuration564000000JPY
Dividends income noiCurrentYTDDuration500000000JPY
Commission fee noiPrior1YTDDuration795000000JPY
Commission fee noiCurrentYTDDuration818000000JPY
Other noiPrior1YTDDuration418000000JPY
Other noiCurrentYTDDuration585000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass